Brazil Bans Import of Lupin APIs
Source: Press Trust of India
Jul 09, 2015
Brazilian drug regulator ANVISA has suspended import of active pharmaceutical ingredients produced by India's Lupin citing "unsatisfactory inputs" and GMP deviations.
According to ANVISA, it has suspended imports of "all beta-lactam cephalosporin pharmaceutical ingredients and all imported drugs using these inputs" manufactured by Lupin.
A Lupin spokesperson says ANVISA had inspected the cephalosporin facility near Bhopal in central India and had certain observations, which have since been addressed.
Read the Profit article
Join the discussion
We welcome your thoughtful comments.
All comments will display your user name.
Comments
No one has commented on this page yet.
RSS feed for comments on this page | RSS feed for all comments